Role of Annexin 7 (ANXA7) as a Tumor Suppressor and a Regulator of Drug Resistance in Thyroid Cancer
Alakesh Bera, Surya Radhakrishnan, Narayanan Puthillathu, Madhan Subramanian, Nahbuma Gana, Eric Russ, Harvey B Pollard, Meera Srivastava, Yan-Fang Xian, Patrick Ming-Kuen Tang, Dongmei Zhang · 2024
Read Role of Annexin 7 (ANXA7) as a Tumor Suppressor and a Regulator of Drug Resistance in Thyroid Cancer by Alakesh Bera, Surya Radhakrishnan, Narayanan Puthillathu, Madhan Subramanian, Nahbuma Gana, Eric Russ, Harvey B Pollard, Meera Srivastava, Yan-Fang Xian, Patrick Ming-Kuen Tang, Dongmei Zhang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642894.txt.
Description
Alakesh Bera and colleagues investigated a membrane protein, annexin A7, as a brake on thyroid cancer and a lever against drug resistance. Thyroid cancer is the commonest endocrine malignancy in the United States and usually curable. The stubborn cases are those that stop responding to standard drugs. Over sixty percent carry the BRAF V600E mutation. Sequencing and protein profiling showed annexin A7 levels reduced in cancer cells, especially BRAF-mutant ones.
Blocking BRAF and its partner MEK raised annexin A7 again. That rise cut a growth signal and switched on cell-death pathways. A second protein, the cell-cycle brake p21, also shaped resistance to BRAF drugs. Raising both proteins together markedly increased cancer cell death. The twenty twenty-four study nominates a two-protein strategy for tumors that have escaped targeted therapy.
Catalog record
| CREATOR | Alakesh Bera, Surya Radhakrishnan, Narayanan Puthillathu, Madhan Subramanian, Nahbuma Gana, Eric Russ, Harvey B Pollard, Meera Srivastava, Yan-Fang Xian, Patrick Ming-Kuen Tang, Dongmei Zhang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |